CHICAGO (AP) -- U.S. doctors haven’t seen a new drug-coated stent heart device for years, but that could change soon if the Endeavor stent from Medtronic Inc. wins U.S. regulatory approval. The Minneapolis-based company expects approval by the end of this year.
